Basel Medical (BMGL) Long-Term Investments (2025)

Basel Medical (BMGL) posted Long-Term Investments of $77.16 for Q4 2025, up 104.97% sequentially from $37.64 in Q2 2025.

Basel Medical (BMGL) Long-Term Investments (2025) Analysis & Trends

Basel Medical has reported Long-Term Investments for 1 years, with the latest figure at $77.16 in Q4 2025.

  • Quarterly Long-Term Investments changed N/A year-over-year to $77.16 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $77.16 (changed N/A YoY) and the FY2025 annual result came in at $39.0, changed N/A from the prior year.
  • Long-Term Investments grew to $77.16 in Q4 2025 per BMGL's latest filing, from $37.64 in the prior quarter.
  • Over five years, Long-Term Investments peaked at $77.16 in Q4 2025 and troughed at $37.64 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 HCA Healthcare 88.19 Bn 90.61 Bn 15.19 Bn 813.00 Mn
2 Tenet Healthcare 21.59 Bn 21.56 Bn 4.45 Bn 3.80 Bn
3 Encompass Health 12.19 Bn 12.86 Bn 1.34 Bn -
4 Davita 11.52 Bn 12.39 Bn 1.16 Bn 183.80 Mn
5 Ensign 10.59 Bn 10.27 Bn 306.24 Mn -
6 Universal Health Services 8.79 Bn 8.72 Bn 3.29 Bn -
7 Pacs 7.04 Bn 6.88 Bn 338.46 Mn -
8 Chemed 6.96 Bn 6.92 Bn 221.47 Mn 148.15 Mn
9 Concentra Group Holdings Parent 4.52 Bn 4.38 Bn 192.10 Mn -
10 Basel Medical 98.81 Mn 98.02 Mn - 77.16

Historic Data

Download Data
DateValue
Dec 31, 2025 77.16
Jun 30, 2025 37.64